APO RESEARCH · REPORT
Prostaglandin
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Product & engineering
Understand the product.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Selected research
Industry Research
Prostaglandin Industry Research Report 2026
Market perspective
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
Read the full market overview
Report Scope
This report quantifies the global Prostaglandin market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prostaglandin Market by Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Prostaglandin Segment by Type
Human Prostaglandin
Veterinary Prostaglandin
Prostaglandin Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Prostaglandin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prostaglandin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prostaglandin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Prostaglandin
- Veterinary Prostaglandin
Applications
- Cardiovascular
- Gynecological and Obstetrical
- Ophthalmologic
- Other
Companies covered
- Sanofi CEPiA
- Kyowa Hakko Pharma
- Cayman Chemical
- Yonsung Fine Chemicals
- Johnson Matthey
- Chirogate
- Everlight Chemical
- ANVI Pharma
- AUSUN Pharmaceutical
- Aspen Biopharma Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prostaglandin Market Size (2021-2032)
- 2.2.2 Global Prostaglandin Sales (2021-2032)
- 2.2.3 Global Prostaglandin Market Average Price (2021-2032)
- 2.3 Prostaglandin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Human Prostaglandin
- 2.3.3 Veterinary Prostaglandin
- 2.4 Prostaglandin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cardiovascular
- 2.4.3 Gynecological and Obstetrical
- 2.4.4 Ophthalmologic
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prostaglandin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prostaglandin Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Prostaglandin Revenue of Manufacturers (2021-2026)
- 3.4 Global Prostaglandin Average Price by Manufacturers (2021-2026)
- 3.5 Global Prostaglandin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prostaglandin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prostaglandin, Product Type & Application
- 3.8 Global Manufacturers of Prostaglandin, Established Date
- 3.9 Global Prostaglandin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi CEPiA
- 4.1.1 Sanofi CEPiA Company Information
- 4.1.2 Sanofi CEPiA Business Overview
- 4.1.3 Sanofi CEPiA Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi CEPiA Prostaglandin Product Portfolio
- 4.1.5 Sanofi CEPiA Recent Developments
- 4.2 Kyowa Hakko Pharma
- 4.2.1 Kyowa Hakko Pharma Company Information
- 4.2.2 Kyowa Hakko Pharma Business Overview
- 4.2.3 Kyowa Hakko Pharma Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kyowa Hakko Pharma Prostaglandin Product Portfolio
- 4.2.5 Kyowa Hakko Pharma Recent Developments
- 4.3 Cayman Chemical
- 4.3.1 Cayman Chemical Company Information
- 4.3.2 Cayman Chemical Business Overview
- 4.3.3 Cayman Chemical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cayman Chemical Prostaglandin Product Portfolio
- 4.3.5 Cayman Chemical Recent Developments
- 4.4 Yonsung Fine Chemicals
- 4.4.1 Yonsung Fine Chemicals Company Information
- 4.4.2 Yonsung Fine Chemicals Business Overview
- 4.4.3 Yonsung Fine Chemicals Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yonsung Fine Chemicals Prostaglandin Product Portfolio
- 4.4.5 Yonsung Fine Chemicals Recent Developments
- 4.5 Johnson Matthey
- 4.5.1 Johnson Matthey Company Information
- 4.5.2 Johnson Matthey Business Overview
- 4.5.3 Johnson Matthey Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson Matthey Prostaglandin Product Portfolio
- 4.5.5 Johnson Matthey Recent Developments
- 4.6 Chirogate
- 4.6.1 Chirogate Company Information
- 4.6.2 Chirogate Business Overview
- 4.6.3 Chirogate Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chirogate Prostaglandin Product Portfolio
- 4.6.5 Chirogate Recent Developments
- 4.7 Everlight Chemical
- 4.7.1 Everlight Chemical Company Information
- 4.7.2 Everlight Chemical Business Overview
- 4.7.3 Everlight Chemical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Everlight Chemical Prostaglandin Product Portfolio
- 4.7.5 Everlight Chemical Recent Developments
- 4.8 ANVI Pharma
- 4.8.1 ANVI Pharma Company Information
- 4.8.2 ANVI Pharma Business Overview
- 4.8.3 ANVI Pharma Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ANVI Pharma Prostaglandin Product Portfolio
- 4.8.5 ANVI Pharma Recent Developments
- 4.9 AUSUN Pharmaceutical
- 4.9.1 AUSUN Pharmaceutical Company Information
- 4.9.2 AUSUN Pharmaceutical Business Overview
- 4.9.3 AUSUN Pharmaceutical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AUSUN Pharmaceutical Prostaglandin Product Portfolio
- 4.9.5 AUSUN Pharmaceutical Recent Developments
- 4.10 Aspen Biopharma Labs
- 4.10.1 Aspen Biopharma Labs Company Information
- 4.10.2 Aspen Biopharma Labs Business Overview
- 4.10.3 Aspen Biopharma Labs Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aspen Biopharma Labs Prostaglandin Product Portfolio
- 4.10.5 Aspen Biopharma Labs Recent Developments
5 Global Prostaglandin Market Scenario by Region
- 5.1 Global Prostaglandin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prostaglandin Sales by Region: 2021-2032
- 5.2.1 Global Prostaglandin Sales by Region: 2021-2026
- 5.2.2 Global Prostaglandin Sales by Region: 2027-2032
- 5.3 Global Prostaglandin Revenue by Region: 2021-2032
- 5.3.1 Global Prostaglandin Revenue by Region: 2021-2026
- 5.3.2 Global Prostaglandin Revenue by Region: 2027-2032
- 5.4 North America Prostaglandin Market Facts & Figures by Country
- 5.4.1 North America Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prostaglandin Sales by Country (2021-2032)
- 5.4.3 North America Prostaglandin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prostaglandin Market Facts & Figures by Country
- 5.5.1 Europe Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prostaglandin Sales by Country (2021-2032)
- 5.5.3 Europe Prostaglandin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prostaglandin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prostaglandin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prostaglandin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prostaglandin Market Facts & Figures by Country
- 5.7.1 South America Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prostaglandin Sales by Country (2021-2032)
- 5.7.3 South America Prostaglandin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Prostaglandin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prostaglandin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prostaglandin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prostaglandin Sales by Type (2021-2032)
- 6.1.1 Global Prostaglandin Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Prostaglandin Sales Market Share by Type (2021-2032)
- 6.2 Global Prostaglandin Revenue by Type (2021-2032)
- 6.2.1 Global Prostaglandin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prostaglandin Revenue Market Share by Type (2021-2032)
- 6.3 Global Prostaglandin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prostaglandin Sales by Application (2021-2032)
- 7.1.1 Global Prostaglandin Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Prostaglandin Sales Market Share by Application (2021-2032)
- 7.2 Global Prostaglandin Revenue by Application (2021-2032)
- 7.2.1 Global Prostaglandin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prostaglandin Revenue Market Share by Application (2021-2032)
- 7.3 Global Prostaglandin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prostaglandin Value Chain Analysis
- 8.1.1 Prostaglandin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prostaglandin Production Mode & Process
- 8.2 Prostaglandin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prostaglandin Distributors
- 8.2.3 Prostaglandin Customers
9 Global Prostaglandin Analyzing Market Dynamics
- 9.1 Prostaglandin Industry Trends
- 9.2 Prostaglandin Industry Drivers
- 9.3 Prostaglandin Industry Opportunities and Challenges
- 9.4 Prostaglandin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst